Bristol Myers Squibb has formed a broad partnership with Hengrui Pharma, paying $600 million upfront to advance 13 early-stage programs from across the two companies’ pipelines. The deal could be ...
Of the 13 programs that the companies will advance, four will come from Hengrui Pharma and four from Bristol Myers Squibb. The remaining five assets will be jointly discovered. Bristol Myers Squibb ...
Abstract: Battery monitoring is vital for most electric vehicles (EVs), because the safety, operation, and even the life of the passenger depends on the battery system. This attribute is exactly the ...
Abstract: Recently, a severe danger has evolved regarding the explosion of Electric Vehicle (EV) batteries due to their thermal issues. A proficient system is employed for managing the operations of ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--2seventy bio, Inc. (Nasdaq: TSVT), today announced a definitive merger agreement under which Bristol Myers Squibb (NYSE: BMY) (“BMS”) will acquire all of the ...
This project is a rewrite of [low-cost-bms][1] for a new hardware platform based on the cheap and powerful STM32. A BMS, or battery management system, is an essential part of any multi battery Lithium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results